AzTrials
AzTrials

Pediculus Capitis InfestationPhase 4NCT06332872

Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand

A Phase 4 study testing Oral Ivermectin and 4% dimenticone liquid gel in people with Pediculus Capitis Infestation and Permethrin Adverse Reaction, run by Phramongkutklao College of Medicine and Hospital at 1 site in Thailand.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to Comparison effectiveness of Oral ivermectin , 1% Permethrin shampoo and 4% Dimeticone liquid gel in the treatment of Pediculosis capitis, to assess the prevalence of lice and associated risk factors between severity groups by using questionnaire-based surveys and diagnostic tests… Read more about this study

Who is it for?
Ages 6 to 13 years
What is being tested?
Oral Ivermectin and 4% dimenticone liquid gel
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
117 participants
Where
1 siteThailand
Study dates
15 Dec 2023to May 2024
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • The participants are studying in Na Yao border patrol police school, Ban Na Isan border patrol police school or Phu Ngam wittaya school.
  • Approved consent from the participants' caretaker

Who cannot join

  • History of Allergic sensitization to these substances
  • The participants with chronic scalp disorder
  • Those who had used a pediculicide within the previous two weeks
  • Those who had recently used bleaches, dyes, or permanent wave products
  • Anyone taking trimethoprim or cotrimoxazole at evaluation or during the previous four weeks
  • Those who had participated in another clinical trial within one month
Show all 10Show fewer
  • Additional exclusion criteria for ivermectin
  • Pregnancy
  • Body weight < 20 kg.
  • Loss to follow up in a second dose

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Phramongkutklao college of medicine

    Bangkok

Other trials in Thailand

About this study

The goal of this clinical trial is to Comparison effectiveness of Oral ivermectin , 1% Permethrin shampoo and 4% Dimeticone liquid gel in the treatment of Pediculosis capitis, to assess the prevalence of lice and associated risk factors between severity groups by using questionnaire-based surveys and diagnostic tests among school children in Baan Nayao, Chachoengsao Province, Thailand.

The main questions it aims to answer are

Read more
  • What is more effective between Oral ivermectin , 1% Permethrin shampoo and 4%Dimeticone liquid gel in the treatment of Pediculosis capitis in school children in Baan Nayao, Chachoengsao Province, Thailand?
  • What is Prevalence and risk factors of being infected with in head lice in school and community?
  • What is Side effects of Oral ivermectin , 1% Permethrin shampoo and 4%Dimeticone liquid gel?

Participants will receive three different drugs are

  • oral ivermectin
  • 4% Dimeticone liquid gel
  • 1% Permethrin shampoo

Participants voluntarily received oral ivermectin as per medical prescription, with treatment outcomes, side effects, and satisfaction levels monitored following two treatment cycles. Those exhibiting persistent lice infestations were subsequently treated with 1% permethrin shampoo, the standard treatment, while alternatives were provided for individuals allergic to permethrin. These findings will contribute to formulating tailored, effective, and safe treatment regimens for future patients.

Read the detailed description

Study design :

The study consists of two study designs: a quantitative study using a cross-sectional study to investigate the prevalence of head lice infestation and identify risk factors of head lice infestation among groups of population diagnosed with varying degrees of infestation; heavy, medium, and light. Additionally, a field trial will be conducted to compare the effectiveness of oral ivermectin, 1% Permethrin shampoo, and 4% Dimethicone liquid gel for treatment of Pediculosis capitis on days 0, 7, 14, and 28.

Study population :

The study population consists of students aged between 6 and 13 years old attending three schools located in Tha Kradan Subdistrict, Sanam Chai Khet District, Chachoengsao Province. The treatment allocation for head lice infestation is as follows: students at Na Yao border patrol police school will receive oral ivermectin, students at Ban Na Isan border patrol police school will receive 4% Dimethicone liquid gel, and students at Phu Ngam Wittaya School will receive 1% Permethrin shampoo. All volunteer groups must obtain consent by signing a parental consent form before participating in the project.

Sample size calculation :

Based on the previous study, Permethrin has an efficacy of 40%, while Ivermectin has an efficacy of 86.7%. By calculating the sample size using the formula for comparing proportions in two population groups, we obtain a sample size of 21 per group. To account for potential loss to follow-up or inability to contact participants, a 20% loss to follow-up rate is added, resulting in a final sample size of 26 individuals per group. Therefore, 78 individuals will be included in the data collection process.

Data collection :

Data collection was based on two questionnaires and data on head lice infection. The first questionnaire was a pre-treatment questionnaire asking for informed consent and a questionnaire regarding basic information. Factors that may be related to lice infection were the parents of the subjects who completed the questionnaire because the subjects were under 14 years of age. The second post-treatment questionnaire recorded information about allergic reactions. Potential adverse side effects of using the three groups of drugs and the number of lice from the second combing.

Data collection on lice infection in this study was based on methods from previous studies. Where lice infestation is defined as the presence of live lice. This is checked using a nit comb to check for live lice in the sunlight. Detection of nits with the ability to survive will also be considered positive. In this research Live lice can be checked by using a nit comb. The level of lice infection is divided into high levels. medium and little High levels of lice infestation means finding more than one lice after combing 1 time. Moderate lice infestation means finding lice after combing 1 time, an amount equal to 1 lice, and low level lice infestation means not found lice on the first attempt, but live lice or eggs were found after 20 rounds of combing and inspecting the area above the ears and below the neck. A nit comb was given to each participant to prevent lice from being infected through the head.

Protocol :

The data collection process began with the give a letter explaining information about the research and a request for informed consent document to participants. Those interested in participating in the research will go through a screening process for lice infection by the research team. The volunteer's identity was verified to match the code set by the researcher. Screening for history of drug allergies that volunteers in each group will receive. Along with informing volunteers and parents of how to give the medicine, including possible side effects and how to behave. In the first lice test, those diagnosed with lice were asked to complete a questionnaire about factors associated with lice infecting subjects with different levels of lice. Next, take oral ivermectin, wash your hair with 1% Permethrin shampoo and leave it for 10 minutes, or marinate your hair with 4% Dimeticone liquid gel and leave it for 15 minutes according to the school group that is divided. Then rinse off with clean water. Subsequently, follow-up was performed by screening for lice infection after drug use on days 0, 7, 14 and 28 of all samples. On day 7, results for all 3 groups were followed up and a second treatment was given in the Oral group. Ivermectin and 1% Permethrin shampoo are administered as the first dose. and follow up on the results of the treatment of lice in all 3 groups on the 14th and 28th day after receiving the first dose. The researcher will fill out a second questionnaire asking for information about allergies and side effects. Then the lice are scraped and a sample is collected and counted. Live lice, dead lice, and larval eggs Then the researcher will record all the numbers and information in the questionnaire.

Being tested
Oral Ivermectin, 4% dimenticone liquid gel
Keywords
Pediculosis capitis, head lice, pediculicides, School, Children, Permethrin, Shampoo, Ivermectin, Dimenticone, gel, liquid gel, pediculosis
Medical subject headings
Lice Infestations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Oral IvermectinDrug

    Oral formulation (3mg tablet) Dosage: 2 single doses of 200 mcg/kg given 7 days apart

  • 4% dimenticone liquid gelDrug

    topical formulation (liquid gel) only 1 application

Study groups in NCT06332872
Study groupRoleWhat they receive
Oral ivermectinExperimentalFor the treatment of head lice infestation, participants are receiving two single doses of oral ivermectin on days 0 and 7 of the experiment. (spaced 7 days apart)
Receives: Drug: Oral Ivermectin
Dimeticone liquid gelExperimentalFor the treatment of head lice infestation, participants are receiving one application of 4% dimenticone liquid gel on day 0 of the experiment.
Receives: Drug: 4% dimenticone liquid gel
Permethrin shampooNo interventionParticipants are receiving two applications of 1% permethrin shampoo, which is the current drug of choice for Pediculosis capitis, on days 0 and 7. This group is defined as a control group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison effectiveness of Oral ivermectin , 1% Permethrin shampoo and 4% Dimeticone liquid gel in the treatment of Pediculosis capitis

    Treatment of Pediculosis capitis was considered effective by the absence of live lice

    Measured: From enrollment to the end of treatment at 28 days

Secondary outcomes (3)
  1. Prevalence of head louse infestation among school children in Chachoengsao Province, Thailand

    Determined with a fine-toothed de-lousing comb to detect living head lice under natural sunlight by combing the hair 20 times in each portion of hair and visual observation above the ears and along the nape of the neck. The detection of viable nits (louse eggs) and nymphs is also considered positive.

    Measured: From enrollment to the end of screening at 28 days

  2. Side effects of Oral ivermectin , 1% Permethrin shampoo and 4%Dimeticone liquid gel

    collected by post-treatment questionnaire about symptoms and allergic reactions after receive the treatment; oral Ivermectin, 4% Dimenticone liquid gel, or 1% Permethrin shampoo

    Measured: From enrollment to the end of treatment at 28 days

  3. The association factor of head lice infestation among school children in Chachoengsao Province, Thailand

    Collected by pre-treatment questionnaire about factors that may be related to lice infection. The parents of the subjects will complete the questionnaire because the subjects were under 14 years of age.

    Measured: From the enrollment to the end of treatment at 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2024
  2. Study start15 Dec 2023
  3. Primary completion18 Mar 2024
  4. Study completionMay 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
117 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06332872
Sponsor's protocol ID
M046q/66
Status last verified
Mar 2024
First submitted
20 Mar 2024
Last updated
27 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Vannaratha A, Buakaew S, Santiwananont N, Srisub T, Sutthithum A, Reugjui S, Julsurang P, Lueang-Urai H, Liamsakul W, Boonsombat R, Luenpan P, Thangto S, Ruang-Areerate T, Kaeothaisong N, Suwanpakdee D, Suwannahitatorn P. Comparative Effectiveness of Oral Ivermectin, 1% Permethrin Shampoo, and 4% Dimethicone Liquid Gel in Treatment of Pediculosis Capitis among School Children in Chachoengsao Province, Thailand. Am J Trop Med Hyg. 2026 Jul 21:tpmd260082. doi: 10.4269/ajtmh.26-0082. Online ahead of print.

    PubMed 42480517

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Oral Ivermectin and 4% dimenticone liquid gel in people with Pediculus Capitis Infestation and Permethrin Adverse Reaction, run by Phramongkutklao College of Medicine and Hospital at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison effectiveness of Oral ivermectin , 1% Permethrin shampoo and 4% Dimeticone liquid gel in the treatment of Pediculosis capitis (time frame: From enrollment to the end of treatment at 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06332872, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in